Although there were some initial concerns, increased rates of pancreatitis or pancreatic cancer have not been seen in meta-analysis
Effect of 26 weeks of liraglutide treatment on coronary artery inflammation in type 2 diabetes quantified by [(64)Cu]Cu-DOTATATE PET/CT: results from the LIRAFLAME trial
And it's really, you know, it's not just the way you look in the mirror, but it's being the healthiest version of yourself and really emphasizing on health," Widmer said
Poll: GLP-1 Drugs and Obesity Policy & Medicare Spending on Ozempic and Other GLP-1 Drugs. 8
GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution By Donnisa Edmonds, C2ST Intern, University of Chicago In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management